NCT05017194

Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm

Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm: Randomized Two Stages Phase II Seamless Adaptive Controlled Single-blind Trials

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 442 (actual)
• Sponsor: Jennifer Keiser · Academic / Other
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The rationale of the study is to provide evidence on the efficacy and safety of Emodepside in adults infected with Trichuris trichiura and hookworm.

Conditions

• Trichuris Trichiura; Infection
• Hookworm Infections

Interventions

Type	Name	Description
DRUG	Emodepside	Treatment with ascending doses of emodepside (from 5 mg to 30 mg) or albendazole (400 mg) or placebo.

Timeline

• Start date: 2021-08-02
• Primary completion: 2021-12-10
• Completion: 2021-12-10
• First posted: 2021-08-23
• Last updated: 2022-05-27

Locations

1 site across 1 country: Tanzania